LAST NEWS
7 January 2019
Number of shares and voting rights as at 31/12/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December. Read the press release
4 January 2019
Half-year report on liquidity contract as at 31/12/2018
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2018. Read the release
7 December 2018
Update on funding prospects
As stated in the previous press release, Europlasma Group and its management are actively pursuing the objective of achieving a capital increase allowing the entry of a reference…
5 December 2018
Number of shares and voting rights as at 30/11/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th November. Read the press release
12 November 2018
Suspension of the automatic issuance of the 4th warrant given access to convertible bonds
Europlasma has suspended, today, the 4th warrant given access to notes convertible into new shares (BEOCA). Read the press release (in French)
6 November 2018
Number of shares and voting rights as at 31/10/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October. Read the press release
12 October 2018
Europlasma announces the reactivation of the financing agreement by issuance of convertible bonds
In the press release of September 3, 2018, Europlasma (the "Company") announced the suspension of the exercise of the third warrant given access to convertible bonds ("OCA") relating to the…
4 October 2018
Number of shares and voting rights as at 30/09/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September. Read the press release (in French)
27 September 2018
General Meeting of Shareholders on 27 September 2018
Quorum achieved: all resolutions suported by the Board of Directors have been approved Group's activity update Read the press release